Curevo Inc clinical trials
Acquired by Eli Lilly and Company, Jul 2026 · source ↗
The registry lists 2 studies whose lead sponsor is Curevo Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 30, 2025.
- 2studies on the registry
- 0open to participants now
Before and after it joined Eli Lilly and Company
- First submitted before Curevo Inc became part of Eli Lilly and Company
- 2
- First submitted after Curevo Inc became part of Eli Lilly and Company
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
All 2 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 119
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Curevo Inc2 studies
Something wrong with this grouping? Tell us on the Eli Lilly and Company page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Eli Lilly and Company studies →
- Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and OlderActive, not recruitingNCT05304351Phase 2
Sponsor listed in the registry: Curevo Inc · First submitted before Curevo Inc became part of Eli Lilly and Company
- Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult SubjectsCompletedNCT03820414Phase 1
Sponsor listed in the registry: Curevo Inc · First submitted before Curevo Inc became part of Eli Lilly and Company